Ranbaxy launches Valaciclovir tablets in US – 27th Nov 09

Ranbaxy launches Valaciclovir tablets in US; Valtrex has annual sales of over $ 2 Bn in US; Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period: PharmAsiaNews
Ranbaxy launches Valaciclovir tablets in US reports CNBC TV18 quoting PharmAsiaNews.com. Valaciclovir is branded as Valtrex by GSK. Valtrex has annual sales of over $ 2 Bn in US. Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period. Ranbaxy has ‘First To File’ status for Valaciclovir.

Also Read :  New Mutual Fund Offers

Related posts:

1. US Court rules Ranbaxy’s generic valganciclovir does not infringe Roche’s Valcyte patent In a verdict on the patent litigation between Roche Palo Alto and the Daiichi-Ranbaxy...
2. impax settles patent litigation with Boehringer Ingelheim impax settles patent litigation with Boehringer Ingelheim for drug Flomax; Impax settlement may mean...
3. Ranbaxy Labs Q3FY09 standalone net profit of Rs 186.1 crore Ranbaxy Labs has announced its Q3FY09 results. It has reported standalone net profit of Rs...
4. Asian markets were trading weak – 27th Nov 09 Asian markets were trading weak. China’s Shanghai Composite was down 1.08% or 34.37 points at...
5. Maytas Infra buzzing in today’s trade -9th Nov 09 Maytas Infra buzzing in today’s trade; up over 7%; company got Pune-Sholapur road contract worth...